articleCephalalgiaFeb 1, 2025HYBRID OA

Setting higher standards for migraine prevention: A position statement of the International Headache Society

SSSimona SaccoMAMessoud AshinaHDHans‐Christoph DienerFHFaraidoon HaghdoostMJMi Ji Lee

University of L'Aquila · University of Copenhagen · +24 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Migraine is one of the most prevalent and disabling neurological diseases, significantly affecting quality of life and productivity, as well as contributing to substantial societal costs. Recent innovations, including calcitonin gene-related peptide (CGRP) pathway inhibitors and onabotulinumtoxinA, have transformed migraine prevention by offering high efficacy and excellent tolerability, thus improving adherence. Clinical trials and real-world studies show that significant reductions in migraine frequency and, in some cases, complete migraine freedom is achievable. In this Position Statement, we advocate for raising the standards of migraine prevention by setting ambitious treatment goals aimed at optimal…

Citation impact

48
total citations
FWCI
51.96
Percentile
100%
References
49
Citations per year

Authors

18

Topics & keywords

Topics
Keywords
  • Migraine
  • Medicine
  • Tolerability
  • Position statement
  • Clinical trial
  • Quality of life (healthcare)
  • Triptans
  • Position paper
UN Sustainable Development Goals
  • Decent work and economic growth
No related works found for this paper.

Funding